PDF下载 ( 1196 KB)
-
摘要:
门静脉高压症(PHT)与肝内循环、体循环和门体侧支循环的血流动力学改变有关。肝内阻力增加和高动力循环侧支血管的扩张在门静脉高压的发病机理中起到了重要作用。不同严重程度的肝硬化均存在能广泛影响人体的血流动力学紊乱。门静脉高压和高动力循环是肝硬化患者发病和死亡的主要原因。而血管结构重塑和血管新生是治疗门静脉高压症的重要目标。
Abstract:Portal hypertension (PHT) is the most common cause of cirrhosis.Since portal pressure is dependent upon intrahepatic resistance and splanchnic blood flow, hemodynamic changes in intrahepatic, systemic, and portosystemic collateral circulation can contribute to or be affected by its perturbation.Intrahepatic vascular regulation and development of intrahepatic resistance involve multiple cellular and molecular mechanisms, such as hepatic stellate cells and sinusoidal endothelial cells and nitric oxide (NO) signaling, especially through the endothelial nitric oxide synthase (eNOS) .Studies have implicated increased intrahepatic resistance and hyperdynamic circulatory alterations with expansion of collateral circulation as playing central roles in the pathogenesis of PHT.A detailed understanding of these processes in PHT is critical to developing effective treatment options and reducing the currently high rates of morbidities and mortality related to hemodynamic alterations in patients with cirrhosis.In this review, the roles of PHT-related vascular remodeling on severity and complications (including cardiac, kidney, and pulmonary) of cirrhosis, and of collateral circulation angiogenesis are discussed, as they represent potential targets for treatment of portal hypertension.
-
Key words:
- hypertension /
- portal /
- liver cirrhosis
-
[1]Zhou JS, Zhang HQ.Analysis on surgical treatment of pa-tients with portal hypertension[J].Chin Med Herald, 2011, 8 (5) :156-157. (in Chinese) 周建生, 张会青.门静脉高压症患者的外科治疗分析[J].中国医药导报, 2011, 8 (5) :156-157. [2]Guturu P, Shah V.New insights into the pathobiology of por-tal Hypertension[J].Hepatol Res, 2009, 39 (10) :1016-1019. [3]Kim MY, Baik SK.Pathophysiology of portal hypertension, what's new?[J].Korean Gastroenterol, 2010, 56 (3) :129-134. [4]Langer DA, Shah VH.Nitric oxide and portal hypertension:interface of Vasor-Eactivity and angiogenesis[J].Hepatol, 2006, 44 (1) :209-216. [5]Lee JS, Semela D, Iredale J, et al.Sinusoidal remodelingand angiogenesis:a new function for the liver-specific peri-cyte?[J].Hepatology, 2007, 45 (3) :817-825. [6]Yokomori H, Oda M, Yoshimura K, et al.Elevated expres-sion of caveolin-1 at protein and mRNA level in human cir-rhotic liver:relation with nitric oxide[J].Gastroenterol, 2003, 38 (9) :854-860. [7]Liu S, Premont RT, Kontos CD, et al.A crucial role forGRK2 in regulation of endothelial cell nitric oxide synthasefunction in portal hypertension[J].Nat Med, 2005, 11 (9) :952-958. [8]Perri RE, Langer DA, Chatterjee S, et al.Defects in cGMP-PKG pathway contribute to impaired NO-dependent respon-ses in hepatic stellate cells upon activation[J].Physiol Gas-trointest Liver Physiol, 2006, 290 (3) :G535-542. [9]Zafra C, Abraldes JG, Turnes J, et al.Simvastatin lowersportal pressure in patients with cirrhosis and portal hyperten-sion:a randomized controlled trial[J].Gastroenterology, 2009, 136 (5) :1651-1658. [10]Cohen-Naftaly M, Friedman SL.Current status of novel an-tifibrotic therapies in patients with chronic liver disease[J].Therap Adv Gastroenterol, 2011, 4 (6) :391-417. [11]Ceni E, Crabb DW, Foschi M, et al.Acetaldehyde inhibitsPPARgamma via H2O2-mediated c-Abl activation in hu-man hepatic stellate cells[J].Gastroenterology, 2006, 131 (4) :1235-1252. [12]Straub AC, Klei LR, Stolz DB, et al.Arsenic requires sphin-gosine-1-phosphate type 1 receptors to induce angiogenicgenes and endothelial cell remodeling[J].Pathol, 2009, 174 (5) :1949-1958. [13]Fernández-Varo G, Ros J, Morales-Ruiz M, et al.Nitri-cide synthase 3-dependent vascular remodeling and circula-tory dysfunction in cirrhosis[J].Pathol, 2003, 162 (6) :1985-1993. [14]Goulis J, Armonis A, Patch D, et al.Bacterial infection is in-dependently associated with failure to control bleeding in cir-rhotic patients with gastrointestinal hemorrhage[J].Hepa-tology, 1998, 27 (5) :1207-1212. [15]Li Y, Song D, Zhang Y, et al.Effect of neonatal capsaicintreatment on haemodynamics and renal function in cirrhoticrats[J].Gut, 2003, 52 (2) :293-299. [16]M ller S, Henriksen JH.Cirrhotic cardiomyopathy[J].Hepa-tol, 2010, 53 (1) :179-190. [17]Ruiz-del-Arbol L, Urman J, Fernández J, et al.Systemic, renal, and hepatic hemodynamic derangement in cirrhotic pa-tients with Sponta Neous bacterial peritonitis[J].Hepatolo-gy, 2003, 38 (5) :1210-1218. [18]Naritaka Y, Ogawa K, Shimakawa T, et al.Clinical experi-ence of transjugular intrahepatic portosystemic shunt (TIPS) and its effects on systemic hemodynamics[J].Hepatogas-troente Rology, 2004, 51 (59) :1470-1472. [19]Fallon MB.Portopulmonary hypertension:new clinical insightsand more questions on pathogenesis[J].Hepatology, 2003, 37 (2) :253-255. [20]Higashiyama R, Moro T, Nakao S, et al.Negligible contribu-tion of bone marrow-derived cells to collagen productionduring hepatic fibrogenesis in mice[J].Gastroenterology, 2009, 137 (4) :1459-1466. [21]Maruyama H, Yokosuka O.Pathophysiology of portal hyper-tension and esophageal varices[J].Inter J Heptol, 2012.[Epub of print] -
本文二维码
计量
- 文章访问数: 3253
- HTML全文浏览量: 12
- PDF下载量: 774
- 被引次数: 0
下载:
